Newsletter - Inovotion - Which molecule will stand out

Topics discussed:

And where to meet us in the first months of 2024 !!!

Topics that will be discussed.

Our latest peer-reviewed publication in "Frontiers in Immunology" on the chicken embryo’s relevance for immune-based studies
Metastasis assay and webinar
Our numbers. What we have achieved with our customers in the last 6 years
Client poster. Weill Cornell Medicine-Qatar
Client testimonial. Affilogics
Our clients' publications
Events – Where to meet us in 2022

Topics that will be discussed.

Inovotion will attend IMMUNO WEEK, Dr. Wang's presentation: The CAM assay, a powerful in vivo model for fast efficacy validation in immuno-oncology
Inovotion has two new in vivo assays for angiogenesis!
Client publication, Michael Lisanti, MD-PhD, FRSA, FRSB, FRSC and collaborators
Client testimonial, SynDevRx, Inc.
Client visit, Research Director Isabelle Mus-Veteau, CNRS, IPMC
Webinar Series
Upcoming events where you can meet us

Topics that will be discussed.

WHITE PAPER : A game-changing preclinical testing model for synergistic immuno-oncology drung discovery
Fast and cost-effective solutions for in-vivo anticancer drug evaluation, using the chicken embryo model
Inovotion expand it's R&D team!
Daudi-Rituximab assay
An unique in-vivo model for fast ADC efficacity ranking: The chicken embryo's cambased assay

Topics that will be discussed.

Here at INOVOTION we sincerely wish you all a Happy New Year from the entire team!
INOVOTION’s poster has been recognized as one of the 4 best posters at the AIS Congress 2020, 1st ex aequo in the industry category!
$ 1million R&D contract awarded
BioTheryX, Inc. renews its confidence with INOVOTION for preclinical in vivo efficacy evaluation of their compounds
Preclinical evaluation of antimetastasic drug candidates using a next generation chicken embryo model

Topics that will be discussed.

New webinar Preclinical Evaluation of Anti-metastatic Drug Candidates using a Next-Generation Chicken Embryo Model
The latest publication led by Dr. Anna Halama, Assistant Professor of Research in Physiology & Biophysics
R&D Booster project: a 900k€ project for deepening our understanding of cancer mechanisms and other diseases
FAQ: Can experiments to study metastasis be conducted on Inovotion's model?

Topics that will be discussed.

Webinar: how to optimize in vivo preclinical efficacy evaluation of synergistic immuno-oncology drug candidates
New publication: Inhibition of patched drug efflux increases vemurafenib effectiveness against resistant brafv600e melanoma
Free webinar: combination approach: a breakthrough in vivo model for high-value identification of oncology candidates
New standardised cell lines
Faq: Is the chicken embryo model considered animal testing? Do you need to address ethical regulations to perform studies on the chicken embryo model?

Topics that will be discussed.

Inovotion is showcasing its technology via the NC3Rs’ CRACK IT Solutions partnering programme.
Jean Viallet, INOVOTION’s CEO and founder, invited to testify on technology transfer, met Frédérique Vidal, French Minister for Advanced Education, Research and Innovation
Chick Embryo Chorioallantoic Membrane: a suitable and easy-to-use model for Photodynamic Therapies. An article from the University of Coimbra
New standardized cell lines
FAQ: Is the chicken embryo model considered animal testing? Do you need to address ethical regulations to perform studies on the chicken embryo model?

Topics that will be discussed.

New cancer model for in vivo efficacy evaluation in the chicken embryo model: effect of cytarabine on the acute myeloid leukemia (aml) cell line mv4-11
A real in vivo model without regulatory constraints.
Presentation by jean viallet, phd, inovotion’s founder, on anti-pd-1/anti-pd-l1 therapies at the meet2win conference.
Ais 2019: inovotion will give a talk and introduce latest developments in in vivo efficacy and safety screening.
Latest developed cell lines
Events – where to meet us

Topics that will be discussed.

Early in vivo evaluation assays for immune-modulation of anti-PD-1 / anti-PD-L1 based combinations.
More than 40 cell lines and 17 reference compounds tested and ready to use for efficacy assays
Publication featuring INOVOTION’s platform: Genoscience Pharma evaluated their most advanced compound, GNS561, with the chick embryo model
Events – Where to meet us